Skip to Content
You are currently on the new version of our website. Access the old version .

155 Results Found

  • Feature Paper
  • Article
  • Open Access
22 Citations
9,825 Views
27 Pages

Agricultural Water Management Using Two-Stage Channels: Performance and Policy Recommendations Based on Northern European Experiences

  • Kaisa Västilä,
  • Sari Väisänen,
  • Jari Koskiaho,
  • Virpi Lehtoranta and ,
  • Krister Karttunen,
  • Mikko Kuussaari,
  • Juha Järvelä and
  • Kauko Koikkalainen
  • + 3 authors+ 0 author

20 August 2021

Conventional dredging of ditches and streams to ensure agricultural drainage and flood mitigation can have severe environmental impacts. The aim of this paper is to investigate the potential benefits of an alternative, nature-based two-stage channel...

(This article belongs to the Section Sustainable Water Management)
  • Article
  • Open Access
4 Citations
2,450 Views
10 Pages

“CAPA in Progress”: A New Real-Life Approach for the Management of Critically Ill COVID-19 Patients

  • Nieves Carbonell,
  • María Jesús Alcaráz,
  • Ainhoa Serrano-Lázaro,
  • María Rodríguez-Gimillo and ,
  • David Sánchez Ramos,
  • Francisco Ros,
  • Josep Ferrer,
  • María Luisa Blasco,
  • David Navarro and
  • María Ángeles Clari
  • + 5 authors+ 0 author

(1) Background: COVID-19-associated pulmonary aspergillosis (CAPA) has worsened the prognosis of patients with pneumonia and acute respiratory distress syndrome admitted to the intensive care unit (ICU). The lack of specific diagnosis criteria is an...

(This article belongs to the Special Issue Non-antiviral Agents for Treatment of COVID-19)
  • Article
  • Open Access
12 Citations
3,708 Views
9 Pages

Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave

  • Robbert G. Bentvelsen,
  • Andreas L. E. Van Arkel,
  • Tom A. Rijpstra,
  • Merijn K. M. Kant and ,
  • Simone Van Der Sar-Van Der Brugge,
  • Daan W. Loth,
  • Peter Van Wijngaarden,
  • Arthur W. F. Du Mée,
  • David C. Y. Yick and
  • Paul E. Verweij
  • + 11 authors+ 6 authors

19 January 2022

Background: Critically ill COVID-19 patients have proven to be at risk for developing invasive fungal infections. However, the incidence and impact of possible/probable COVID-19-associated pulmonary aspergillosis (CAPA) in severe COVID-19 patients va...

(This article belongs to the Special Issue When Viruses and Fungi Act Together)
  • Review
  • Open Access
95 Citations
8,635 Views
20 Pages

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)

  • Simon Feys,
  • Maria Panagiota Almyroudi,
  • Reinout Braspenning,
  • Katrien Lagrou and ,
  • Isabel Spriet,
  • George Dimopoulos and
  • Joost Wauters
  • + 2 authors+ 0 author

11 December 2021

Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and prospective studies have been performed to get a better grasp on this l...

(This article belongs to the Special Issue When Viruses and Fungi Act Together)
  • Brief Report
  • Open Access
3 Citations
2,351 Views
7 Pages

Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA)

  • María Ruiz-Ruigómez,
  • Mario Fernández-Ruiz,
  • Ana Pérez-Ayala and
  • José María Aguado

11 August 2022

COVID-19-associated pulmonary aspergillosis (CAPA) have been documented during the COVID-19 pandemic. The vast majority of these patients do not meet the classic EORTC/MSGERC criteria for invasive pulmonary aspergillosis. The question arises as to wh...

(This article belongs to the Special Issue Aspergillus Infections—Virulence and Host Response)
  • Article
  • Open Access
221 Views
19 Pages

Immune Profile and Risk of COVID-19-Associated Pulmonary Aspergillosis (CAPA): A Multicenter Retrospective Study with Matching Cohorts

  • Olivier Mascle,
  • Claire Dupuis,
  • Antoine Lafarge,
  • Maxime Moniot and ,
  • Bertrand Evrard,
  • Philippe Poirier,
  • Adrien Joseph,
  • Elie Azoulay,
  • Guillaume Dumas and
  • Bertrand Souweine
  • + 12 authors+ 7 authors

10 October 2026

Background: The anti-inflammatory effects of COVID-19 and its treatment may promote COVID-19-associated pulmonary aspergillosis (CAPA). This study aimed to investigate the immunological profile associated with CAPA in ICU patients. Methods: We conduc...

(This article belongs to the Special Issue Aspergillus Infections, Diagnostics and Antifungal Treatment)
  • Case Report
  • Open Access
12 Citations
4,498 Views
11 Pages

Mixed Etiology COVID-19 Associated Pulmonary Aspergillosis (CAPA)—A Case Report and Brief Review of the Literature

  • Dan Alexandru Toc,
  • Carmen Costache,
  • Alexandru Botan,
  • Razvan Marian Mihaila and ,
  • Ioana Alina Colosi,
  • Sandor Botond Buksa and
  • Roxana Mihaela Chiorescu
  • + 2 authors+ 0 author

18 October 2021

The SARS-CoV-2 pandemic has proved to be a significant risk addition for invasive infections with Aspergillus. Even though there are plenty of data about the COVID-19-associated pulmonary aspergillosis (CAPA), especially involving Aspergillus fumigat...

(This article belongs to the Special Issue Respiratory Fungal Infections)
  • Article
  • Open Access
535 Views
11 Pages

COVID-19-associated pulmonary aspergillosis (CAPA) is a frequent and severe complication among critically ill patients with COVID-19. The absence of a clear diagnostic gold standard and the multiplicity of proposed definitions (EORTC/MSG, AspICU, and...

(This article belongs to the Section Medical Microbiology)
  • Case Report
  • Open Access
7 Citations
3,454 Views
6 Pages

A Clinical Case of COVID-19-Associated Pulmonary Aspergillosis (CAPA), Illustrating the Challenges in Diagnosis (Despite Overwhelming Mycological Evidence)

  • P. Lewis White,
  • Jan Springer,
  • Matt P. Wise,
  • Hermann Einsele and ,
  • Claudia Löffler,
  • Michelle Seif,
  • Sabrina Prommersberger,
  • Matthijs Backx and
  • Jürgen Löffler
  • + 4 authors+ 0 author

14 January 2022

The COVID-19 pandemic has resulted in large numbers of patients requiring critical care management. With the established association between severe respiratory virus infection and invasive pulmonary aspergillosis (7.6% for COVID-19-associated pulmona...

(This article belongs to the Special Issue Respiratory Fungal Infections)
  • Article
  • Open Access
10 Citations
4,673 Views
19 Pages

Biphasic CAPA-IVM Improves Equine Oocyte Quality and Subsequent Embryo Development Without Inducing Genetic Aberrations

  • Muhammad Fakhar-I-Adil,
  • Daniel Angel-Velez,
  • Emin Araftpoor,
  • Qurratul Ain Amin and ,
  • Mohamed Hedia,
  • Marcel Bühler,
  • Kris Gevaert,
  • Björn Menten,
  • Ann Van Soom and
  • Björn Heindryckx
  • + 9 authors+ 4 authors

In vitro maturation (IVM) of oocytes retrieved from ovum pick-up (OPU) or ovarian tissue (OT) is a standard approach for patients with specific conditions where prior hormonal stimulation is contraindicated. However, the developmental competence of o...

(This article belongs to the Special Issue Molecular Research on Embryo Developmental Potential)
  • Review
  • Open Access
6 Citations
3,992 Views
15 Pages

As the global SARS-CoV-2 pandemic continues to plague healthcare systems, it has become clear that opportunistic pathogens cause a considerable proportion of SARS-CoV-2-associated mortality and morbidity cases. Of these, Covid-Associated Pulmonary As...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
4 Citations
2,959 Views
12 Pages

Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave—A Single Center Experience

  • Simon Dubler,
  • Ömer Can Turan,
  • Karsten Daniel Schmidt,
  • Peter-michael rath and ,
  • Hedda-Luise Verhasselt,
  • Sandra Maier,
  • Annabell Skarabis,
  • Thorsten Brenner and
  • Frank Herbstreit
  • + 4 authors+ 0 author

5 December 2022

Superinfections with Aspergillus spp. in patients with Coronavirus disease 2019 (CAPA: COVID-19-associated pulmonary aspergillosis) are increasing. Dexamethasone has shown beneficial effects in critically ill COVID-19 patients. Whether dexamethasone...

(This article belongs to the Special Issue Diagnosis of Invasive Aspergillosis on ICU)
  • Article
  • Open Access
7 Citations
3,119 Views
14 Pages

Comparison of Multi-locus Genotypes Detected in Aspergillus fumigatus Isolated from COVID Associated Pulmonary Aspergillosis (CAPA) and from Other Clinical and Environmental Sources

  • Susana Morais,
  • Cristina Toscano,
  • Helena Simões,
  • Dina Carpinteiro and ,
  • Carla Viegas,
  • Cristina Veríssimo and
  • Raquel Sabino
  • + 2 authors+ 0 author

24 February 2023

Background: Aspergillus fumigatus is a saprophytic fungus, ubiquitous in the environment and responsible for causing infections, some of them severe invasive infections. The high morbidity and mortality, together with the increasing burden of triazol...

(This article belongs to the Special Issue Biology, Immunology, Epidemiology, and Therapy of Fungal Infections: A Themed Issue Dedicated to Professor David A. Stevens)
  • Article
  • Open Access
7 Citations
3,118 Views
8 Pages

A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data

  • Cornelia Lass-Flörl,
  • Miriam Knoll,
  • Wilfried Posch,
  • Michael Joannidis and ,
  • Timo Mayerhöfer,
  • Robert Breitkopf and
  • Romuald Bellmann
  • + 2 authors+ 0 author

30 December 2022

(1) Background: Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) raises concerns to contribute to an increased mortality. The incidence of CAPA varies widely within hospitals and countries, partly because of difficulties...

(This article belongs to the Special Issue Diagnosis of Invasive Aspergillosis on ICU)
  • Article
  • Open Access
4 Citations
4,192 Views
17 Pages

COVID-19-Associated Pulmonary Aspergillosis (CAPA) in Northern Greece during 2020–2022: A Comparative Study According to the Main Consensus Criteria and Definitions

  • Panagiotis Siasios,
  • Kostoula Arvaniti,
  • Evangelia Zachrou,
  • Aikaterini Poulopoulou and ,
  • Pinelopi Pisanidou,
  • Georgia Vasileiadou,
  • Evangelos Kaimakamis,
  • Athina Georgopoulou,
  • Foteini Renta and
  • Timoleon-Achilleas Vyzantiadis
  • + 22 authors+ 17 authors

5 January 2023

Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) has emerged as an important complication among patients with acute respiratory failure due to SARS-CoV-2 infection. Almost 2.5 years since the start of the COVID-19 pandemi...

(This article belongs to the Special Issue Diagnostic and Therapeutic Challenges of Human Fungal Infections)
  • Article
  • Open Access
13 Citations
8,583 Views
20 Pages

Adenovirus E1A/E1B Transformed Amniotic Fluid Cells Support Human Cytomegalovirus Replication

  • Natascha Krömmelbein,
  • Lüder Wiebusch,
  • Gudrun Schiedner,
  • Nicole Büscher and ,
  • Caroline Sauer,
  • Luise Florin,
  • Elisabeth Sehn,
  • Uwe Wolfrum and
  • Bodo Plachter
  • + 4 authors+ 0 author

2 February 2016

The human cytomegalovirus (HCMV) replicates to high titers in primary human fibroblast cell cultures. A variety of primary human cells and some tumor-derived cell lines do also support permissive HCMV replication, yet at low levels. Cell lines establ...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
23 Citations
5,553 Views
13 Pages

COVID-19 Associated Pulmonary Aspergillosis (CAPA): Hospital or Home Environment as a Source of Life-Threatening Aspergillus fumigatus Infection?

  • Teresa Peláez-García de la Rasilla,
  • Irene González-Jiménez,
  • Andrea Fernández-Arroyo,
  • Alejandra Roldán and ,
  • Jose Luis Carretero-Ares,
  • Marta García-Clemente,
  • Mauricio Telenti-Asensio,
  • Emilio García-Prieto,
  • Mar Martínez-Suarez and
  • María Luisa Sánchez-Núñez
  • + 10 authors+ 5 authors

19 March 2022

Most cases of invasive aspergillosis are caused by Aspergillus fumigatus, whose conidia are ubiquitous in the environment. Additionally, in indoor environments, such as houses or hospitals, conidia are frequently detected too. Hospital-acquired asper...

(This article belongs to the Special Issue Fungal Infections and COVID-19)
  • Article
  • Open Access
14 Citations
3,504 Views
11 Pages

Association of COVID-19-Associated Pulmonary Aspergillosis with Cytomegalovirus Replication: A Case–Control Study

  • Jorge Calderón-Parra,
  • Victor Moreno-Torres,
  • Patricia Mills-Sanchez,
  • Sandra Tejado-Bravo and ,
  • Isabel Romero-Sánchez,
  • Bárbara Balandin-Moreno,
  • Marina Calvo-Salvador,
  • Francisca Portero-Azorín,
  • Sarela García-Masedo and
  • Ana Fernández-Cruz
  • + 7 authors+ 2 authors

6 February 2022

Introduction: Cytomegalovirus (CMV) infection is a well-known factor associated with invasive aspergillosis in immunocompromised hosts. However, its association with COVID-19-associated pulmonary aspergillosis (CAPA) has not been described. We aimed...

(This article belongs to the Special Issue Fungal Infections and COVID-19)
  • Article
  • Open Access
8 Citations
3,485 Views
36 Pages

Genomic Epidemiology Identifies Azole Resistance Due to TR34/L98H in European Aspergillus fumigatus Causing COVID-19-Associated Pulmonary Aspergillosis

  • Benjamin C. Simmons,
  • Johanna Rhodes,
  • Thomas R. Rogers,
  • Paul E. Verweij and ,
  • Alireza Abdolrasouli,
  • Silke Schelenz,
  • Samuel J. Hemmings,
  • Alida Fe Talento,
  • Auveen Griffin and
  • Matthew C. Fisher
  • + 8 authors+ 3 authors

13 November 2023

Aspergillus fumigatus has been found to coinfect patients with severe SARS-CoV-2 virus infection, leading to COVID-19-associated pulmonary aspergillosis (CAPA). The CAPA all-cause mortality rate is approximately 50% and may be complicated by azole re...

(This article belongs to the Special Issue Azole Resistance in Aspergillus spp.)
  • Article
  • Open Access
5 Citations
3,240 Views
10 Pages

Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis

  • H. Carlo Maurer,
  • David Schult,
  • Plamena Koyumdzhieva,
  • Sandra Reitmeier and ,
  • Moritz Middelhoff,
  • Sebastian Rasch,
  • Markus List,
  • Klaus-Peter Janssen,
  • Katja Steiger and
  • Tobias Lahmer
  • + 10 authors+ 5 authors

30 November 2022

Objectives: COVID-19 disease can be exacerbated by Aspergillus superinfection (CAPA). However, the causes of CAPA are not yet fully understood. Recently, alterations in the gut microbiome have been associated with a more complicated and severe diseas...

(This article belongs to the Special Issue Aspergillus Infections—Virulence and Host Response)
  • Article
  • Open Access
19 Citations
3,339 Views
12 Pages

Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit—A Monocentric Retrospective Observational Study

  • Emilien Gregoire,
  • Benoit François Pirotte,
  • Filip Moerman,
  • Antoine Altdorfer and ,
  • Laura Gaspard,
  • Eric Firre,
  • Martial Moonen,
  • Vincent Fraipont,
  • Marie Ernst and
  • Gilles Darcis
  • + 5 authors+ 0 author

22 October 2021

Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is an increasingly recognized complication of COVID-19 and is associated with significant over-mortality. We performed a retrospective monocentric study in patients admitte...

(This article belongs to the Special Issue Aspergillosis)
  • Article
  • Open Access
19 Citations
4,122 Views
12 Pages

COVID-19-Associated Pulmonary Aspergillosis in a Tertiary Hospital

  • García-Clemente Marta,
  • Forcelledo-Espina Lorena,
  • Martínez-Vega Laura,
  • Lanza-Martínez Angela and ,
  • Leoz-Gordillo Blanca,
  • Albillos-Almaraz Rodrigo,
  • Solís-García Marta,
  • Melón-García Santiago,
  • Pérez-Martínez Liliana and
  • Peláez-García de la Rasilla Teresa
  • + 6 authors+ 1 author

19 January 2022

Our study aims to assess the prevalence of CAPA (COVID-19-associated pulmonary aspergillosis) and describe the associated risk factors and their impact on mortality. A prospective study was conducted. We included patients with COVID-19 disease who we...

(This article belongs to the Special Issue Diagnosis and Treatment of Fungus and Virus Interaction)
  • Article
  • Open Access
17 Citations
4,239 Views
11 Pages

COVID-19-Associated Pulmonary Aspergillosis in Russia

  • Olga Shadrivova,
  • Denis Gusev,
  • Maria Vashukova,
  • Dmitriy Lobzin and ,
  • Vitaliy Gusarov,
  • Mikhail Zamyatin,
  • Anatoliy Zavrazhnov,
  • Mikhail Mitichkin,
  • Yulia Borzova and
  • Working Group
  • + 12 authors+ 7 authors

10 December 2021

We studied the risk factors, etiology, clinical features and the effectiveness of therapy of COVID-19-associated pulmonary aspergillosis (CAPA) in adult patients. In this retrospective study, we included 45 patients with proven (7%) and probable (93%...

(This article belongs to the Special Issue When Viruses and Fungi Act Together)
  • Communication
  • Open Access
15 Citations
2,748 Views
11 Pages

Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study

  • Felix Bergmann,
  • Anselm Jorda,
  • Amelie Blaschke,
  • Cornelia Gabler and ,
  • Serhii Bohdan,
  • Alina Nussbaumer-Pröll,
  • Christine Radtke and
  • Markus Zeitlinger
  • + 3 authors+ 0 author

3 March 2023

COVID-19-associated pulmonary aspergillosis (CAPA) is a life-threatening fungal infection that mainly affects critically ill patients. The aim of this study was to assess the incidence and clinical outcomes of putative CAPA in critically ill COVID-19...

(This article belongs to the Section Fungal Pathogenesis and Disease Control)
  • Case Report
  • Open Access
6 Citations
3,136 Views
7 Pages

COVID-19-Associated Pulmonary Aspergillosis: A Year-Long Retrospective Case Series

  • Barbara Salas,
  • Iain McCullagh,
  • Katie Cranfield,
  • Christine Fagan and ,
  • Angela Geering and
  • Ali Robb
  • + 1 author+ 0 author

21 July 2022

COVID-19-associated pulmonary aspergillosis (CAPA) refers to co-infection with Aspergillus spp. in patients with COVID-19. It has a higher mortality rate when compared with patients only infected with COVID-19, but we still know little about the epid...

  • Article
  • Open Access
18 Citations
4,578 Views
10 Pages

COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility

  • Nina Lackner,
  • Claudius Thomé,
  • Dietmar Öfner,
  • Michael Joannidis and ,
  • Timo Mayerhöfer,
  • Rohit Arora,
  • Eldina Samardzic,
  • Wilfried Posch,
  • Robert Breitkopf and
  • Cornelia Lass-Flörl
  • + 5 authors+ 0 author

18 January 2022

Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) raises concerns as to whether it contributes to an increased mortality. The incidence of CAPA varies widely within hospitals and countries, partly because of difficulties i...

(This article belongs to the Special Issue When Viruses and Fungi Act Together)
  • Article
  • Open Access
21 Citations
3,259 Views
16 Pages

Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data

  • Giacomo Casalini,
  • Andrea Giacomelli,
  • Laura Galimberti,
  • Riccardo Colombo and ,
  • Elisabetta Ballone,
  • Giacomo Pozza,
  • Martina Zacheo,
  • Miriam Galimberti,
  • Letizia Oreni and
  • Spinello Antinori
  • + 10 authors+ 5 authors

23 August 2022

Critically ill COVID-19 patients can develop invasive pulmonary aspergillosis (CAPA). Considering the weaknesses of diagnostic tests/case definitions, as well as the results from autoptic studies, there is a debate on the real burden of aspergillosis...

(This article belongs to the Special Issue Fungal Infections in COVID-19 Patients)
  • Review
  • Open Access
9 Citations
3,827 Views
13 Pages

26 November 2022

The COVID-19 pandemic has redemonstrated the importance of the fungal-after-viral phenomenon, and the question of whether prophylaxis should be used to prevent COVID-19-associated pulmonary aspergillosis (CAPA). A distinct pathophysiology from invasi...

(This article belongs to the Section Antibiotics Use and Antimicrobial Stewardship)
  • Article
  • Open Access
49 Citations
6,218 Views
13 Pages

Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?

  • Florian Reizine,
  • Kieran Pinceaux,
  • Mathieu Lederlin,
  • Brice Autier and ,
  • Hélène Guegan,
  • Arnaud Gacouin,
  • David Luque-Paz,
  • Christelle Boglione-Kerrien,
  • Astrid Bacle and
  • Jean-Pierre Gangneux
  • + 16 authors+ 11 authors

15 May 2021

Invasive pulmonary aspergillosis (IPA) in intensive care unit patients is a major concern. Influenza-associated acute respiratory distress syndrome (ARDS) and severe COVID-19 patients are both at risk of developing invasive fungal diseases. We used t...

(This article belongs to the Special Issue When Viruses and Fungi Act Together)
  • Review
  • Open Access
17 Citations
3,367 Views
16 Pages

Mortality in ICU Patients with COVID-19-Associated Pulmonary Aspergillosis

  • Anna Beltrame,
  • David A. Stevens and
  • Donna Haiduven

20 June 2023

A review of 38 studies involving 1437 COVID-19 patients admitted to intensive care units (ICUs) with pulmonary aspergillosis (CAPA) was conducted to investigate whether mortality has improved since the pandemic’s onset. The study found that the...

(This article belongs to the Special Issue Biology, Immunology, Epidemiology, and Therapy of Fungal Infections: A Themed Issue Dedicated to Professor David A. Stevens)
  • Article
  • Open Access
10 Citations
3,820 Views
10 Pages

COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020–March 2021

  • Geetha Sivasubramanian,
  • Hebah Ghanem,
  • Michele Maison-Fomotar,
  • Ratnali Jain and
  • Robert Libke

10 November 2021

Reports of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) have been widely published across the world since the onset of the pandemic with varying incidence rates. We retrospectively studied all patients with severe COV...

(This article belongs to the Special Issue Fungal Infections and COVID-19)
  • Review
  • Open Access
65 Citations
7,770 Views
12 Pages

Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature

  • Anna Apostolopoulou,
  • Zerelda Esquer Garrigos,
  • Prakhar Vijayvargiya,
  • Alexis Hope Lerner and
  • Dimitrios Farmakiotis

10 October 2020

In this systematic review, we investigate the epidemiology, pathogenesis, risk factors, clinical manifestations, diagnosis and treatment of COVID-19-associated pulmonary aspergillosis (CAPA). We identified 85 cases from 22 studies. The frequency of C...

(This article belongs to the Section Diagnostic Microbiology and Infectious Disease)
  • Review
  • Open Access
11 Citations
3,745 Views
12 Pages

Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets

  • Alessandro Russo,
  • Helen Linda Morrone,
  • Salvatore Rotundo,
  • Enrico Maria Trecarichi and
  • Carlo Torti

During the SARS-CoV-2 pandemic, a higher incidence of invasive pulmonary aspergillosis was observed in patients affected by Coronavirus disease 2019 (COVID-19), leading to the delineation of a new entity named COVID-19 associated pulmonary aspergillo...

(This article belongs to the Section Diagnostic Microbiology and Infectious Disease)
  • Communication
  • Open Access
1,951 Views
6 Pages

12 November 2024

Caffeic acid phenethyl ester (CAPE) is a phenolic natural product with diverse biological activities, notably anticancer properties. However, its ester group is metabolically unstable. The amide derivative, CAPA, offers improved metabolic stability t...

(This article belongs to the Section Natural Product Chemistry)
  • Review
  • Open Access
12 Citations
4,880 Views
21 Pages

Isavuconazole for COVID-19-Associated Invasive Mold Infections

  • Nadir Ullah,
  • Chiara Sepulcri and
  • Malgorzata Mikulska

28 June 2022

Isavuconazole is a broad-spectrum antifungal drug recently approved as a first-line treatment for invasive aspergillosis and as a first or alternative treatment for mucormycosis. The purpose of this review was to report and discuss the use of isavuco...

(This article belongs to the Special Issue Fungal Infections and COVID-19)
  • Article
  • Open Access
9 Citations
3,770 Views
15 Pages

COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland

  • Magdalena Skóra,
  • Mateusz Gajda,
  • Magdalena Namysł,
  • Jerzy Wordliczek and ,
  • Joanna Zorska,
  • Piotr Piekiełko,
  • Barbara Żółtowska,
  • Paweł Krzyściak,
  • Piotr B. Heczko and
  • Jadwiga Wójkowska-Mach
  • + 5 authors+ 0 author

13 June 2023

Coronavirus disease 2019 (COVID-19) has been shown to be a favoring factor for aspergillosis, especially in a severe course requiring admission to the intensive care unit (ICU). The aim of the study was to assess the morbidity of CAPA among ICU patie...

(This article belongs to the Special Issue Young Investigator in Fungal Infections, 2nd Edition)
  • Article
  • Open Access
3 Citations
2,584 Views
14 Pages

Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis

  • Marilena Pariano,
  • Anna Gidari,
  • Claudia Stincardini,
  • Sara Pierucci and ,
  • Sabrina Bastianelli,
  • Matteo Puccetti,
  • Stefano Giovagnoli,
  • Marina M. Bellet,
  • Consuelo Fabi and
  • Luigina Romani
  • + 10 authors+ 5 authors

22 July 2024

Aspergillus fumigatus is an environmental fungus recently included in the fungal high-priority pathogens by the World Health Organization. While immunodeficiency and/or pre-existing lung damage represent a well-recognized fertile ground for fungal gr...

(This article belongs to the Section Fungal Pathogenesis and Disease Control)
  • Case Report
  • Open Access
90 Citations
10,811 Views
8 Pages

Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report

  • Eelco F. J. Meijer,
  • Anton S. M. Dofferhoff,
  • Oscar Hoiting,
  • Jochem B. Buil and
  • Jacques F. Meis

6 June 2020

COVID-19-associated pulmonary aspergillosis (CAPA) is a recently described disease entity affecting patients with severe pulmonary abnormalities treated in intensive care units. Delays in diagnosis contribute to a delayed start of antifungal therapy....

(This article belongs to the Special Issue Fungal Infections Complicating COVID-19)
  • Article
  • Open Access
41 Citations
5,127 Views
17 Pages

Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses

  • Lucas Perez,
  • Philippe Corne,
  • Grégoire Pasquier,
  • Céline Konecki and ,
  • Meriem Sadek,
  • Clément Le Bihan,
  • Kada Klouche,
  • Olivier Mathieu,
  • Jacques Reynes and
  • Yoann Cazaubon
  • + 5 authors+ 0 author

6 February 2023

Isavuconazole is a triazole antifungal agent recently recommended as first-line therapy for invasive pulmonary aspergillosis. With the COVID-19 pandemic, cases of COVID-19-associated pulmonary aspergillosis (CAPA) have been described with a prevalenc...

(This article belongs to the Special Issue Fungal Infections in Modern Critical Care Medicine: Advances in Diagnostic and Treatment)
  • Article
  • Open Access
2 Citations
1,875 Views
8 Pages

Impact and Occurrence of Herpesvirus and Aspergillosis Superinfection in Patients with Severe COVID-19 Pneumonia

  • Antoinette D. Reichert,
  • Júlia M. da Silva Voorham,
  • Karin H. Groenewegen and
  • Huub La van den Oever

13 May 2024

Background: Pulmonary superinfections with Herpesviridae and Aspergillus spp. are common in severe coronavirus disease 2019 (COVID-19) pneumonia but their epidemiology and impact remain poorly understood. Methods: We conducted a retrospective observa...

  • Article
  • Open Access
1 Citations
2,495 Views
12 Pages

The Prognostic Role of Diagnostic Criteria for COVID-19-Associated Pulmonary Aspergillosis: A Cross-Sectional Retrospective Study

  • Erika Asperges,
  • Rebecca Pesare,
  • Cecilia Bassoli,
  • Matteo Calia and ,
  • Sonia Lerta,
  • Francesco Citiolo,
  • Giuseppe Albi,
  • Caterina Cavanna,
  • Paolo Sacchi and
  • Raffaele Bruno
  • + 5 authors+ 0 author

Several criteria exist to diagnose pulmonary aspergillosis with varying degrees of certainty in specific populations, including oncohaematological patients (EORTC/MSG), ICU patients (mAspICU) and COVID-19 patients (ECMM). At the beginning of the pand...

  • Case Report
  • Open Access
692 Views
13 Pages

Cold Atmospheric Plasma-Aerosol Treatment of Equine Antibiotic-Resistant Wound Infection: A Preliminary Case Series

  • Sandra Kurras,
  • Theresa Maria Conze,
  • Sinje Obermann,
  • Robert Fuchs and ,
  • Tim Tischendorf,
  • Derek C. Knottenbelt and
  • Marc Koene
  • + 2 authors+ 0 author

3 August 2026

Background: Wound infections are common sequelae of wound treatment in horses. Secondary bacterial colonization with antimicrobial resistant microorganisms is of particular concern and is of crucial importance regarding the “One Health Concept&...

(This article belongs to the Special Issue Advances in Internal Medicine in Equids)
  • Communication
  • Open Access
16 Citations
3,805 Views
14 Pages

Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico

  • Carla M. Roman-Montes,
  • Saul Bojorges-Aguilar,
  • Ever Arturo Corral-Herrera,
  • Andrea Rangel-Cordero and ,
  • Paulette Díaz-Lomelí,
  • Axel Cervantes-Sanchez,
  • Bernardo A. Martinez-Guerra,
  • Sandra Rajme-López,
  • Karla María Tamez-Torres and
  • José Sifuentes-Osornio
  • + 8 authors+ 3 authors

18 May 2023

Background: Invasive Fungal Infections (IFI) are emergent complications of COVID-19. In this study, we aim to describe the prevalence, related factors, and outcomes of IFI in critical COVID-19 patients. Methods: We conducted a nested case–contr...

  • Review
  • Open Access
13 Citations
4,002 Views
13 Pages

Aspergillus-SARS-CoV-2 Coinfection: What Is Known?

  • Carlos Alberto Castro-Fuentes,
  • María del Rocío Reyes-Montes,
  • María Guadalupe Frías-De-León,
  • Omar E. Valencia-Ledezma and ,
  • Gustavo Acosta-Altamirano and
  • Esperanza Duarte-Escalante
  • + 1 author+ 0 author

25 October 2022

COVID-19-associated pulmonary aspergillosis (CAPA) has had a high incidence. In addition, it has been associated with prolonged hospital stays, as well as several predisposing risk factors, such as fungal factors (nosocomial organism, the size of the...

(This article belongs to the Special Issue Opportunistic Fungal Infections)
  • Article
  • Open Access
1 Citations
2,320 Views
22 Pages

IMERG in the Canadian Precipitation Analysis (CaPA) System for Winter Applications

  • Stéphane Bélair,
  • Pei-Ning Feng,
  • Franck Lespinas,
  • Dikra Khedhaouiria and ,
  • David Hudak,
  • Daniel Michelson,
  • Catherine Aubry,
  • Florence Beaudry,
  • Marco L. Carrera and
  • Julie M. Thériault
  • + 5 authors+ 0 author

27 June 2024

Several configurations of the Canadian Precipitation Analysis system (CaPA) currently produce precipitation analyses at Environment and Climate Change Canada (ECCC). To improve CaPA’s performance during the winter season, the impact of assimila...

(This article belongs to the Section Atmospheric Techniques, Instruments, and Modeling)
  • Case Report
  • Open Access
6 Citations
2,971 Views
5 Pages

Mucormycosis in CAPA, a Possible Fungal Super-Infection

  • Paola Saltini,
  • Emanuele Palomba,
  • Valeria Castelli,
  • Marco Fava and ,
  • Laura Alagna,
  • Simona Biscarini,
  • Marco Mantero,
  • Francesco Blasi,
  • Anna Grancini and
  • Andrea Lombardi
  • + 8 authors+ 3 authors

28 August 2021

The occurrence of pulmonary fungal superinfection due to Aspergillus spp. in patients with COVID-19 is a well-described complication associated with significant morbidity and mortality. This can be related to a directed effect of the virus and to the...

  • Article
  • Open Access
2 Citations
2,432 Views
11 Pages

Flow and On-Water Synthesis and Cancer Cell Cytotoxicity of Caffeic Acid Phenethyl Amide (CAPA) Derivatives

  • Anthony Saucedo,
  • Muppidi Subbarao,
  • Mauricio Jemal,
  • Nakya L. Mesa-Diaz and ,
  • Jadyn L. Smith,
  • Alexandra Vernaza,
  • Liqin Du and
  • Sean M. Kerwin
  • + 3 authors+ 0 author

Caffeic acid phenethyl ester (CAPE) is a phenolic natural product with a wide range of biological activities, including anticancer activity; however, the ester group of CAPE is metabolically labile. The corresponding amide, CAPA, has improved metabol...

(This article belongs to the Section Bioactives and Nutraceuticals)
  • Article
  • Open Access
9 Citations
3,439 Views
9 Pages

Tendency in Pulmonary Aspergillosis Investigation during the COVID-19 Era: What Is Changing?

  • Giuseppina Caggiano,
  • Francesca Apollonio,
  • Mila Consiglio,
  • Valentina Gasparre and ,
  • Paolo Trerotoli,
  • Giusy Diella,
  • Marco Lopuzzo,
  • Francesco Triggiano,
  • Stefania Stolfa and
  • Maria Teresa Montagna
  • + 6 authors+ 1 author

Aspergillosis is a disease caused by Aspergillus, and invasive pulmonary aspergillosis (IPA) is the most common invasive fungal infection leading to death in severely immuno-compromised patients. The literature reports Aspergillus co-infections in pa...

(This article belongs to the Special Issue Environmental Hygiene and Health Promotion)
  • Review
  • Open Access
337 Citations
22,060 Views
17 Pages

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

  • Amir Arastehfar,
  • Agostinho Carvalho,
  • Frank L. van de Veerdonk,
  • Jeffrey D. Jenks and ,
  • Philipp Koehler,
  • Robert Krause,
  • Oliver A. Cornely,
  • David S. Perlin,
  • Cornelia Lass-Flörl and
  • Martin Hoenigl
  • + 5 authors+ 0 author

24 June 2020

Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated...

(This article belongs to the Special Issue Fungal Infections Complicating COVID-19)
  • Feature Paper
  • Article
  • Open Access
3 Citations
3,977 Views
18 Pages

Clinical and Microbiological Outcomes and Follow-Up of Secondary Bacterial and Fungal Infections among Critically Ill COVID-19 Adult Patients Treated with and without Immunomodulation: A Prospective Cohort Study

  • Bálint Gergely Szabó,
  • Eszter Czél,
  • Imola Nagy,
  • Dorina Korózs and ,
  • Borisz Petrik,
  • Bence Marosi,
  • Zsófia Gáspár,
  • Martin Rajmon,
  • Márk Di Giovanni and
  • Ilona Bobek
  • + 8 authors+ 3 authors

Background: Nearly 10% of COVID-19 cases will require admission to the intensive care unit (ICU). Our aim was to assess the clinical and microbiological outcomes of secondary infections among critically ill COVID-19 adult patients treated with/withou...

of 4